NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-239-2009-0-US-04 DNA-PROTEIN VACCINATION PROTOCOLS US CON 15/085,903 Abandoned
NCATS E-072-2015-0-KR-13 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMIA KR National Stage 10-2016-7008373 Issued
NHGRI E-044-2013-0-US-06 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) US CON 15/084,255 9833468 Issued PDF
NIAID E-064-2016-0-US-01 RSV F Immunogens and Their Use US 62/314,946 Abandoned
NHLBI E-759-2013-0-US-04 Vascular Dilators US National Stage 15/025,336 10537718 Issued PDF
NCI E-010-2008-0-US-04 Methods and Compositions for Protein Delivery US DIV 15/082,401 1004-08-30 Issued PDF
NCI E-025-2015-0-PCT-02 ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND METHODS PCT PCT PCT/US2016/024531 Expired
NIAID E-248-2006-0-CN-20 "Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus" CN DIV 201610183481.3 Abandoned
NCATS E-116-2016-0-US-01 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE US 62/313,309 Abandoned
NCATS E-036-2016-0-US-01 METHODS OF USING (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE IN THE TREATMENT OF DEPRESSION,ANXIETY, ANHEDONIA,SUICIDAL IDEATION, AND POST TRAUMATIC STRESS DISORDERS US 62/313,317 Abandoned
NIDDK E-067-2010-0-JP-10 Inverse Agonists And Neutral Antagonists For the TSH Receptor JP DIV 2016-059757 Abandoned
NCATS E-088-2016-0-CH-05 Inhibitors Of 12/15-Lipoxygenase CH EP 14837235.2 Issued
NCATS E-088-2016-0-FR-07 Inhibitors Of 12/15-Lipoxygenase FR EP 14837235.2 Issued
NCATS E-088-2016-0-DE-06 Inhibitors Of 12/15-Lipoxygenase DE EP 14837235.2 Issued
NCATS E-088-2016-0-GB-08 Inhibitors Of 12/15-Lipoxygenase GB EP 14837235.2 Issued
NCATS E-088-2016-0-EP-04 Inhibitors Of 12/15-Lipoxygenase EP National Stage 14837235.2 Issued
NCATS E-326-2008-0-US-11 Activators Of Human Pyruvate Kinase US CON 15/076,258 9707230 Issued PDF
NIAID E-219-2016-0-EP-03 Serum Antibody Assay For Determining Protection From Malaria, And Pre-Erythrocytic Subunit Vaccines EP National Stage 14839238.4 Abandoned
NIAID E-131-2015-2-ZA-08 Neutralizing Antibodies to GP120 and Their Use ZA National Stage 2017/06155 Issued
NIAID E-131-2015-2-CN-04 Neutralizing Antibodies to GP120 and Their Use CN National Stage 201680028822.8 Issued
NIAID E-131-2015-2-IN-06 A MONOCLONAL ANTIBODY IN National Stage 201737032671 Issued
NIAID E-131-2015-2-AU-02 Neutralizing Antibodies to GP120 and Their Use AU National Stage 2016235541 Issued
NIAID E-131-2015-2-AT-12 Neutralizing Antibodies to GP120 and Their Use AT EP 16716979.6 Issued
NIAID E-131-2015-2-AL-11 Neutralizing Antibodies to GP120 and Their Use AL EP 16716979.6 Issued
NIAID E-131-2015-2-BE-13 Neutralizing Antibodies to GP120 and Their Use BE EP 16716979.6 Issued
NIAID E-131-2015-2-HU-27 Neutralizing Antibodies to GP120 and Their Use HU EP 16716979.6 Issued
NIAID E-131-2015-2-GR-25 Neutralizing Antibodies to GP120 and Their Use GR EP 16716979.6 Issued
NIAID E-131-2015-2-IE-28 Neutralizing Antibodies to GP120 and Their Use IE EP 16716979.6 Issued
NIAID E-131-2015-2-IS-29 Neutralizing Antibodies to GP120 and Their Use IS EP 16716979.6 Issued
NIAID E-131-2015-2-FI-22 Neutralizing Antibodies to GP120 and Their Use FI EP 16716979.6 Issued
NIAID E-131-2015-2-FR-23 Neutralizing Antibodies to GP120 and Their Use FR EP 16716979.6 Issued
NIAID E-131-2015-2-EE-20 Neutralizing Antibodies to GP120 and Their Use EE EP 16716979.6 Issued
NIAID E-131-2015-2-DE-18 Neutralizing Antibodies to GP120 and Their Use DE EP 16716979.6 Issued
NIAID E-131-2015-2-DK-19 Neutralizing Antibodies to GP120 and Their Use DK EP 16716979.6 Issued
NIAID E-131-2015-2-BG-14 Neutralizing Antibodies to GP120 and Their Use BG EP 16716979.6 Issued
NIAID E-131-2015-2-CY-16 Neutralizing Antibodies to GP120 and Their Use CY EP 16716979.6 Issued
NIAID E-131-2015-2-CZ-17 Neutralizing Antibodies to GP120 and Their Use CZ EP 16716979.6 Issued
NIAID E-131-2015-2-HR-26 Neutralizing Antibodies to GP120 and Their Use HR EP 16716979.6 Issued
NIAID E-131-2015-2-RO-42 Neutralizing Antibodies to GP120 and Their Use RO EP 16716979.6 Issued
NIAID E-131-2015-2-MK-36 Neutralizing Antibodies to GP120 and Their Use MK EP 16716979.6 Issued
NIAID E-131-2015-2-PL-40 Neutralizing Antibodies to GP120 and Their Use PL EP 16716979.6 Issued
NIAID E-131-2015-2-NO-39 Neutralizing Antibodies to GP120 and Their Use NO EP 16716979.6 Issued
NIAID E-131-2015-2-SK-46 Neutralizing Antibodies to GP120 and Their Use SK EP 16716979.6 Issued
NIAID E-131-2015-2-NL-38 Neutralizing Antibodies to GP120 and Their Use NL EP 16716979.6 Issued
NIAID E-131-2015-2-SM-47 Neutralizing Antibodies to GP120 and Their Use SM EP 16716979.6 Issued
NIAID E-131-2015-2-RS-43 Neutralizing Antibodies to GP120 and Their Use RS EP 16716979.6 Issued
NIAID E-131-2015-2-MC-35 Neutralizing Antibodies to GP120 and Their Use MC EP 16716979.6 Issued
NIAID E-131-2015-2-MT-37 Neutralizing Antibodies to GP120 and Their Use MT EP 16716979.6 Issued
NIAID E-131-2015-2-SI-45 Neutralizing Antibodies to GP120 and Their Use SI EP 16716979.6 Issued
NIAID E-131-2015-2-PT-41 Neutralizing Antibodies to GP120 and Their Use PT EP 16716979.6 Issued